{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:11:59Z","timestamp":1794571919392,"version":"4.9.1"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016109","name":"Taishan Industry Leading Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejmech.2022.114291","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T22:41:05Z","timestamp":1647297665000},"page":"114291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":302,"special_numbering":"C","title":["Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective"],"prefix":"10.1016","volume":"235","author":[{"given":"Yongsheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib1","doi-asserted-by":"crossref","first-page":"a011247","DOI":"10.1101\/cshperspect.a011247","article-title":"Toll-like receptor signaling","volume":"5","author":"Lim","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114291_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nri3446","article-title":"The history of Toll-like receptors - redefining innate immunity","volume":"13","author":"O'Neill","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114291_bib4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00109-021-02113-y","article-title":"The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis","volume":"99","author":"Bolourani","year":"2021","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejmech.2022.114291_bib5","doi-asserted-by":"crossref","first-page":"118833","DOI":"10.1016\/j.lfs.2020.118833","article-title":"Autophagy alleviates mitochondrial DAMP-induced acute lung injury by inhibiting NLRP3 inflammasome","volume":"265","author":"Peng","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.ejmech.2022.114291_bib6","doi-asserted-by":"crossref","first-page":"114847","DOI":"10.1016\/j.bcp.2021.114847","article-title":"The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders","volume":"195","author":"Parthasarathy","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114291_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-biochem-060713-035600","article-title":"Biosynthesis and export of bacterial lipopolysaccharides","volume":"83","author":"Whitfield","year":"2014","journal-title":"Annu. Rev. Biochem"},{"issue":"26","key":"10.1016\/j.ejmech.2022.114291_bib8","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1074\/jbc.M117.796631","article-title":"Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1\u2013IKK\u03b5\u2013IRF3 axis activation","volume":"293","author":"Tsukamoto","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114291_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","article-title":"Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling","volume":"72","author":"P\u0142\u00f3ciennikowska","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"503","key":"10.1016\/j.ejmech.2022.114291_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan1308","article-title":"Quantitative single-molecule imaging of TLR4 reveals ligand-specific receptor dimerization","volume":"10","author":"Kr\u00fcger","year":"2017","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114291_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ni1207","article-title":"CD14 is required for MyD88-independent LPS signaling","volume":"6","author":"Jiang","year":"2005","journal-title":"Nat. Immunol."},{"issue":"6851","key":"10.1016\/j.ejmech.2022.114291_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","article-title":"Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction","volume":"413","author":"Fitzgerald","year":"2001","journal-title":"Nature"},{"issue":"6913","key":"10.1016\/j.ejmech.2022.114291_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01180","article-title":"The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors","volume":"420","author":"Horng","year":"2002","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejmech.2022.114291_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni0901-835","article-title":"TIRAP: an adapter molecule in the Toll signaling pathway","volume":"2","author":"Horng","year":"2001","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114291_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012683","article-title":"Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling","volume":"5","author":"Sughra","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ejmech.2022.114291_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092729","article-title":"The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cell.2014.01.019","article-title":"A\u00a0promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction","volume":"156","author":"Bonham","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cell.2006.03.047","article-title":"Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling","volume":"125","author":"Kagan","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.114291_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114291_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1096\/fasebj.9.10.7542214","article-title":"Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers","volume":"9","author":"Collins","year":"1995","journal-title":"Faseb. J."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114291_bib21","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/jsfa.7519","article-title":"Extractable and non-extractable polyphenols from blueberries modulate LPS-induced expression of iNOS and COX-2 in RAW264.7 macrophages via the NF-kappaB signalling pathway","volume":"96","author":"Cheng","year":"2016","journal-title":"J.\u00a0Sci. Food Agric."},{"issue":"3\u20134","key":"10.1016\/j.ejmech.2022.114291_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vetimm.2015.10.003","article-title":"Activation of MEK\/ERK pathways through NF-kappaB activation is involved in interleukin-1beta-induced cyclooxygenase-2 expression in canine dermal fibroblasts","volume":"168","author":"Tsuchiya","year":"2015","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/08830185.2012.706761","article-title":"Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities","volume":"31","author":"Moghimpour Bijani","year":"2012","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1139\/cjpp-2016-0652","article-title":"Calpain inhibitor I attenuates atherosclerosis and inflammation in atherosclerotic rats through eNOS\/NO\/NF-\u03baB pathway","volume":"96","author":"Yu","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib25","doi-asserted-by":"crossref","first-page":"20608","DOI":"10.1038\/s41598-021-98931-8","article-title":"Effect of chitosan on blood profile, inflammatory cytokines by activating TLR4\/NF-\u03baB signaling pathway in intestine of heat stressed mice","volume":"11","author":"Mohyuddin","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/JLB.3MIR1218-483RR","article-title":"Below the surface: the inner lives of TLR4 and TLR9","volume":"106","author":"Marongiu","year":"2019","journal-title":"J.\u00a0Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1042\/BST20160259","article-title":"Functional interfaces between TICAM-2\/TRAM and TICAM-1\/TRIF in TLR4 signaling","volume":"45","author":"Funami","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2008.01.061","article-title":"Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling","volume":"368","author":"Tanimura","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","article-title":"CD14 controls the LPS-induced endocytosis of toll-like receptor 4","volume":"147","author":"Zanoni","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"6227","key":"10.1016\/j.ejmech.2022.114291_bib31","doi-asserted-by":"crossref","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1189\/jlb.2RI1115-531R","article-title":"TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target","volume":"100","author":"Ullah","year":"2016","journal-title":"J.\u00a0Leukoc. Biol."},{"issue":"6131","key":"10.1016\/j.ejmech.2022.114291_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1232578","article-title":"Direct proteomic quantification of the secretome of activated immune cells","volume":"340","author":"Meissner","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114291_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.cr.7310018","article-title":"IRF family proteins and type I interferon induction in dendritic cells","volume":"16","author":"Tailor","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2022.114291_bib35","doi-asserted-by":"crossref","first-page":"101277","DOI":"10.1016\/j.smim.2019.05.001","article-title":"Type I interferon signaling, regulation and gene stimulation in chronic virus infection","volume":"43","author":"Lukhele","year":"2019","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114291_bib36","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.4049\/jimmunol.171.8.4304","volume":"171","author":"Sato","year":"2003","journal-title":"J.\u00a0Immunol."},{"issue":"44","key":"10.1016\/j.ejmech.2022.114291_bib37","doi-asserted-by":"crossref","first-page":"36560","DOI":"10.1074\/jbc.M506831200","article-title":"Rip1 mediates the trif-dependent toll-like receptor 3- and 4-induced NF-\u03baB activation but does not contribute to interferon regulatory factor 3 activation","volume":"280","author":"Cusson-Hermance","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"issue":"7242","key":"10.1016\/j.ejmech.2022.114291_bib38","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4\u2013MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114291_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.immuni.2008.07.007","article-title":"Structures of the toll-like receptor family and its ligand complexes","volume":"29","author":"Jin","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ejmech.2022.114291_bib40","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/eji.200940034","article-title":"SARM inhibits both TRIF- and MyD88-mediated AP-1 activation","volume":"40","author":"Peng","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114291_bib41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/pro.2472","article-title":"Structure of vaccinia virus A46, an inhibitor of TLR4 signaling pathway, shows the conformation of VIPER motif","volume":"23","author":"Kim","year":"2014","journal-title":"Protein Sci"},{"issue":"7242","key":"10.1016\/j.ejmech.2022.114291_bib42","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.ejmech.2022.114291_bib43","doi-asserted-by":"crossref","first-page":"15052","DOI":"10.1074\/jbc.M901429200","article-title":"Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin","volume":"284","author":"Resman","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114291_bib44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/molecules25030627","article-title":"TLR4-Targeting therapeutics: structural basis and computer-aided drug discovery approaches","volume":"25","author":"Ain","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.ejmech.2022.114291_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007228","article-title":"Key residues in TLR4-MD2 tetramer formation identified by free energy simulations","volume":"15","author":"Tafazzol","year":"2019","journal-title":"PLoS Comput. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2014.04.001","article-title":"Sepsis: current dogma and new perspectives","volume":"40","author":"Deutschman","year":"2014","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ejmech.2022.114291_bib47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1315","article-title":"Regulation of lung injury and repair by Toll-like receptors and hyaluronan","volume":"11","author":"Jiang","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2022.114291_bib48","doi-asserted-by":"crossref","first-page":"705080","DOI":"10.3389\/fimmu.2021.705080","article-title":"Targeting TLR4 signaling to blunt viral-mediated acute lung injury","volume":"12","author":"Shirey","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114291_bib49","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/ijms22020816","article-title":"Toll-like receptors in acute kidney injury","volume":"22","author":"Vazquez-Carballo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114291_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/ITT.S288547","article-title":"Contribution of toll-like receptors and the NLRP3 inflammasome in rheumatoid arthritis pathophysiology","volume":"10","author":"Unterberger","year":"2021","journal-title":"ImmunoTargets Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12664-020-01114-y","article-title":"Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation","volume":"40","author":"Tam","year":"2021","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2022.114291_bib52","doi-asserted-by":"crossref","first-page":"579036","DOI":"10.3389\/fcvm.2020.579036","article-title":"Key player in cardiac hypertrophy, emphasizing the role of toll-like receptor 4","volume":"7","author":"Xiao","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"18","key":"10.1016\/j.ejmech.2022.114291_bib53","doi-asserted-by":"crossref","first-page":"10677","DOI":"10.1111\/jcmm.15688","article-title":"Danshen (Salvia miltiorrhiza) restricts MD2\/TLR4-MyD88 complex formation and signalling in acute myocardial infarction-induced heart failure","volume":"24","author":"Wang","year":"2020","journal-title":"J.\u00a0Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib54","doi-asserted-by":"crossref","first-page":"12032","DOI":"10.1038\/s41598-020-68919-x","article-title":"Blockade of the TLR4-MD2 complex lowers blood pressure and improves vascular function in a murine model of type 1 diabetes","volume":"10","author":"de Oliveira","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114291_bib55","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fimmu.2020.00807","article-title":"Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders","volume":"11","author":"Firmal","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib56","doi-asserted-by":"crossref","first-page":"e1121","DOI":"10.1002\/cti2.1121","article-title":"Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury","volume":"9","author":"Robertson","year":"2020","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.ejmech.2022.114291_bib57","doi-asserted-by":"crossref","first-page":"603445","DOI":"10.3389\/fphar.2020.603445","article-title":"Toll-like receptor 4 signaling and drug addiction","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114291_bib58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14728222.2021.1918103","article-title":"TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2","volume":"25","author":"Kaushik","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2022.114291_bib59","doi-asserted-by":"crossref","first-page":"8874339","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114291_bib60","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.drudis.2018.01.015","article-title":"Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.114291_bib61","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3389\/fimmu.2020.01210","article-title":"Increasing the chemical variety of small-molecule-based TLR4 modulators: an overview","volume":"11","author":"Romerio","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114291_bib62","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1097\/00003246-200008000-00005","article-title":"A\u00a0lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia","volume":"28","author":"Bunnell","year":"2000","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/17425255.2011.558190","article-title":"Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies","volume":"7","author":"Barochia","year":"2011","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114291_bib64","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","article-title":"Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model","volume":"157","author":"Takashima","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114291_bib65","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib66","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","article-title":"Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran","volume":"130","author":"Kim","year":"2007","journal-title":"Cell"},{"issue":"36","key":"10.1016\/j.ejmech.2022.114291_bib67","doi-asserted-by":"crossref","first-page":"27935","DOI":"10.1074\/jbc.M110.134668","article-title":"MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA","volume":"285","author":"Meng","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"issue":"30","key":"10.1016\/j.ejmech.2022.114291_bib68","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105316118","article-title":"Sulfatides are endogenous ligands for the TLR4-MD-2 complex","volume":"118","author":"Su","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114291_bib69","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/cb4003199","article-title":"Conformationally constrained lipid A mimetics for exploration of structural basis of TLR4\/MD-2 activation by lipopolysaccharide","volume":"8","author":"Artner","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41598-018-37421-w","article-title":"Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties","volume":"9","author":"Cochet","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114291_bib71","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/acs.jmedchem.7b01803","article-title":"Structure-activity relationship in monosaccharide-based toll-like receptor 4 (TLR4) antagonists","volume":"61","author":"Facchini","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2022.114291_bib72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jep.2005.05.004","article-title":"Chemical diversity of propolis and the problem of standardization","volume":"100","author":"Bankova","year":"2005","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"13","key":"10.1016\/j.ejmech.2022.114291_bib73","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/j.bmcl.2013.05.016","article-title":"Synthesis and neuroprotective effect of E-3,4-dihydroxy styryl aralkyl ketones derivatives against oxidative stress and inflammation","volume":"23","author":"Ning","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114291_bib74","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejmech.2017.11.066","article-title":"Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury","volume":"143","author":"Chen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2022.114291_bib75","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1016\/j.bmcl.2010.07.103","article-title":"Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions","volume":"20","author":"Joce","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib76","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/ml100041f","article-title":"Selection, preparation, and evaluation of small-molecule inhibitors of toll-like receptor 4","volume":"1","author":"Bevan","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.ejmech.2022.114291_bib77","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1021\/jm2003365","article-title":"Development of \u03b2-amino alcohol derivatives that inhibit toll-like receptor 4 mediated inflammatory response as potential antiseptics","volume":"54","author":"Chavez","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114291_bib78","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cyto.2016.09.004","article-title":"Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-kappaB activation and oxidative stress mediators","volume":"88","author":"Amirshahrokhi","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.ejmech.2022.114291_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejmech.2018.05.033","article-title":"Discovery of novel small molecule TLR4 inhibitors as potent anti-inflammatory agents","volume":"154","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114291_bib80","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/biom10121624","article-title":"Acylpolyamine mygalin as a TLR4 antagonist based on molecular docking and in\u00a0vitro analyses","volume":"10","author":"Espinoza-Culup\u00fa","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2022.114291_bib81","series-title":"Cyclic Compound. WO2018047888","author":"Kobayashi","year":"2018"},{"key":"10.1016\/j.ejmech.2022.114291_bib82","series-title":"CYCLIC COMPOUNDS. US2017066737","author":"Toshitake","year":"2017"},{"key":"10.1016\/j.ejmech.2022.114291_bib83","series-title":"Sulfonamide or Amide Compounds, Compositions and Methods for the Prophylaxis And\/Or Treatment of Autoimmune, Inflammation or Infection Related Disorders. WO2018156297","author":"Yang","year":"2018"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114291_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acsmedchemlett.9b00518","article-title":"Design and catalyzed activation of tak-242 prodrugs for localized inhibition of TLR4-induced inflammation","volume":"11","author":"Plunk","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib85","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/bph.13394","article-title":"Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4","volume":"173","author":"Wang","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib86","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajpath.2020.01.008","article-title":"Toll-like receptor-4 antagonist (+)-Naltrexone protects against carbamyl-platelet activating factor (cPAF)-Induced preterm labor in mice","volume":"190","author":"Wahid","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114291_bib87","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1021\/acs.jmedchem.5b00426","article-title":"Structure-activity relationships of (+)-Naltrexone-Inspired toll-like receptor 4 (TLR4) antagonists","volume":"58","author":"Selfridge","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib88","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acs.jcim.7b00717","article-title":"Dissecting the innate immune recognition of opioid inactive isomer (+)-Naltrexone derived toll-like receptor 4 (TLR4) antagonists","volume":"58","author":"Zhang","year":"2018","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2022.114291_bib89","series-title":"Morphinan Derivatives and Compositions Comprising the Same for Treating Autoimmune, Inflammation or Infection Related Disorders. WO2018128798","author":"Lee","year":"2017"},{"issue":"15","key":"10.1016\/j.ejmech.2022.114291_bib90","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1021\/acschemneuro.0c00120","article-title":"Antidepressive effect of arctiin by attenuating neuroinflammation via HMGB1\/TLR4- and TNF-alpha\/TNFR1-mediated NF-kappaB activation","volume":"11","author":"Xu","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114291_bib91","doi-asserted-by":"crossref","first-page":"105037","DOI":"10.1016\/j.bioorg.2021.105037","article-title":"Synthesis and evaluation of the anti-inflammatory activity of novel 8-quinolinesulfonamide derivatives as TLR4\/MD-2 inhibitors with efficacy in adjuvant-induced arthritis","volume":"114","author":"Liu","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2022.114291_bib92","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1016\/j.bmc.2012.08.022","article-title":"Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors","volume":"20","author":"Zhang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114291_bib93","first-page":"1039","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates","volume":"314","author":"Stoll","year":"2015","journal-title":"1993-2012. Jama"},{"issue":"10","key":"10.1016\/j.ejmech.2022.114291_bib94","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrgastro.2016.119","article-title":"Necrotizing enterocolitis: new insights into pathogenesis and mechanisms","volume":"13","author":"Ni\u00f1o","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114291_bib95","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.sempedsurg.2013.01.003","article-title":"Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: toll-like receptors throw the switch","volume":"22","author":"Hackam","year":"2013","journal-title":"Semin. Pediatr. Surg."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib96","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41390-020-0852-3","article-title":"The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling","volume":"89","author":"Sodhi","year":"2021","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejmech.2022.114291_bib97","series-title":"Compositions and Methods for Treatment of Inflammatory Disorders. US 20210128594","author":"Hackam","year":"2021"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib98","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1038\/s41598-019-38731-3","article-title":"Novel chitohexaose analog protects young and aged mice from CLP induced polymicrobial sepsis","volume":"9","author":"Das","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib99","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3390\/ijms22052573","article-title":"Small immunomodulatory molecules as potential therapeutics in experimental murine models of acute lung injury (ALI)\/Acute respiratory distress syndrome (ARDS)","volume":"22","author":"Shah","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib100","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s10753-019-01174-z","article-title":"Protective effect of a novel (2S, 3R, 4S)-Chromene-3-Carboxamide derivative, Z20 against sepsis-induced organ injury","volume":"43","author":"Zeng","year":"2020","journal-title":"Inflammation"},{"issue":"10","key":"10.1016\/j.ejmech.2022.114291_bib101","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/acscombsci.9b00050","article-title":"Diastereoselective synthesis of 3,4-Dihydropyran-3-carboxamides with in\u00a0vitro anti-inflammatory activity","volume":"21","author":"Zeng","year":"2019","journal-title":"ACS Comb. Sci."},{"issue":"75","key":"10.1016\/j.ejmech.2022.114291_bib102","doi-asserted-by":"crossref","first-page":"14140","DOI":"10.1039\/C5CC05204A","article-title":"Moulding calixarenes for biomacromolecule targeting","volume":"51","author":"Giuliani","year":"2015","journal-title":"Chem. Commun."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114291_bib103","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D","article-title":"Animal antimicrobial peptides: an overview","volume":"47","author":"Andreu","year":"1998","journal-title":"Biopolymers"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114291_bib104","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1021\/acs.jmedchem.7b00095","article-title":"Amphiphilic Guanidinocalixarenes inhibit lipopolysaccharide (LPS)- and lectin-stimulated toll-like receptor 4 (TLR4) signaling","volume":"60","author":"Sestito","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114291_bib105","first-page":"CD007402","article-title":"Topical NSAIDs for acute pain in adults","volume":"6","author":"Massey","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2022.114291_bib106","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ijpharm.2016.11.016","article-title":"Oil-in-water nanoemulsions are suitable for carrying hydrophobic compounds: indomethacin as a model of anti-inflammatory drug","volume":"515","author":"Kwasigroch","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114291_bib107","first-page":"FF01","article-title":"In\u00a0vivo and in\u00a0vitro anti-inflammatory activity of indazole and its derivatives","volume":"10","author":"Cheekavolu","year":"2016","journal-title":"J.\u00a0Clin. Diagn. Res."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114291_bib108","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1021\/acs.jmedchem.9b00316","article-title":"Discovery of 3-(Indol-5-yl)-indazole derivatives as novel myeloid differentiation protein 2\/Toll-like receptor 4 antagonists for treatment of acute lung injury","volume":"62","author":"Liu","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib109","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jmb.2010.03.058","article-title":"Determinants of BH3 binding specificity for mcl-1 versus bcl-xL","volume":"398","author":"Dutta","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib110","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1039\/c0cs00029a","article-title":"Studying protein-protein interactions using peptide arrays","volume":"40","author":"Katz","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2022.114291_bib111","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biomaterials.2017.02.023","article-title":"TLR4\/MD2 specific peptides stalled in\u00a0vivo LPS-induced immune exacerbation","volume":"126","author":"Park","year":"2017","journal-title":"Biomaterials"},{"issue":"14","key":"10.1016\/j.ejmech.2022.114291_bib112","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1021\/acs.jmedchem.9b00061","article-title":"Linear and rationally designed stapled peptides abrogate TLR4 pathway and relieve inflammatory symptoms in rheumatoid arthritis rat model","volume":"62","author":"Achek","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib113","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjp.0702596","article-title":"E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide","volume":"127","author":"Kawata","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114291_bib114","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/09680519020080060601","article-title":"Antagonism of in\u00a0vivo and ex\u00a0vivo response to endotoxin by E5564, a synthetic lipid A analogue","volume":"8","author":"Rossignol","year":"2002","journal-title":"J.\u00a0Endotoxin Res."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114291_bib115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.172.1.77","article-title":"Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex\u00a0vivo","volume":"172","author":"Kovach","year":"1990","journal-title":"J.\u00a0Exp. Med."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114291_bib116","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/bph.12091","article-title":"Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2","volume":"168","author":"Kim","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib117","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/ml100041f","article-title":"Selection, preparation, and evaluation of small- molecule inhibitors of toll-like receptor 4","volume":"1","author":"Bevan","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114291_bib118","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejmech.2013.10.019","article-title":"Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening","volume":"70","author":"Svajger","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114291_bib119","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2174\/1573406412666160314151900","article-title":"Synthesis and biological evaluation of N-aryl-N'-(5-(2-hydroxybenzoyl) pyrimidin-2-yl)guanidines as toll-like receptor 4 antagonists","volume":"12","author":"Sova","year":"2016","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114291_bib120","doi-asserted-by":"crossref","first-page":"111307","DOI":"10.1016\/j.fct.2020.111307","article-title":"Crocin attenuates cisplatin-induced hepatotoxicity via TLR4\/NF-\u03baBp50 signaling and BAMBI modulation of TGF-\u03b2 activity: involvement of miRNA-9 and miRNA-29","volume":"140","author":"Khedr","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114291_bib121","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1007\/s12035-018-1280-9","article-title":"Ferulic acid rescues LPS-induced neurotoxicity via modulation of the TLR4 receptor in the mouse Hippocampus","volume":"56","author":"Rehman","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114291_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/187152807781696464","article-title":"Anti-inflammatory responses of resveratrol","volume":"6","author":"Das","year":"2007","journal-title":"Inflamm. Allergy - Drug Targets"},{"issue":"15","key":"10.1016\/j.ejmech.2022.114291_bib123","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1016\/j.bmcl.2013.05.058","article-title":"Inhibitory effect of resveratrol dimerized derivatives on nitric oxide production in lipopolysaccharide-induced RAW 264.7 cells","volume":"23","author":"Zhong","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114291_bib124","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2016.02.021","article-title":"Discovery of novel sesquistilbene indanone analogues as potent anti-inflammatory agents","volume":"113","author":"Tang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114291_bib125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arr.2007.09.002","article-title":"Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging","volume":"7","author":"Salminen","year":"2008","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114291_bib126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejmech.2019.05.004","article-title":"Novel resveratrol-based flavonol derivatives: synthesis and anti-inflammatory activity in\u00a0vitro and in\u00a0vivo","volume":"175","author":"Chen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114291_bib127","doi-asserted-by":"crossref","first-page":"103735","DOI":"10.1016\/j.bioorg.2020.103735","article-title":"Novel paeonol derivatives: design, synthesis and anti-inflammatory activity in\u00a0vitro and in\u00a0vivo","volume":"98","author":"Hu","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114291_bib128","doi-asserted-by":"crossref","first-page":"128315","DOI":"10.1016\/j.bmcl.2021.128315","article-title":"Synthesis, activity and mechanism for double-ring conjugated enones","volume":"49","author":"Zhou","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114291_bib129","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3390\/molecules21121718","article-title":"Scoparone inhibits LPS-simulated inflammatory response by suppressing IRF3 and ERK in BV-2 microglial cells","volume":"21","author":"Cho","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114291_bib130","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.biopha.2018.07.062","article-title":"Scoparone prevents IL-1beta-induced inflammatory response in human osteoarthritis chondrocytes through the PI3K\/Akt\/NF-kappaB pathway","volume":"106","author":"Lu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.114291_bib131","doi-asserted-by":"crossref","first-page":"105797","DOI":"10.1016\/j.intimp.2019.105797","article-title":"Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4\/NF-\u03baB signaling pathway in mice","volume":"75","author":"Liu","year":"2019","journal-title":"Int. Immunopharm."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114291_bib132","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/bph.14595","article-title":"Loganetin protects against rhabdomyolysis-induced acute kidney injury by modulating the toll-like receptor 4 signalling pathway","volume":"176","author":"Li","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114291_bib133","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41401-020-00502-6","article-title":"Ruscogenin attenuates particulate matter-induced acute lung injury in mice via protecting pulmonary endothelial barrier and inhibiting TLR4 signaling pathway","volume":"42","author":"Wang","year":"2021","journal-title":"Acta Pharmacol. Sin."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:38:28Z","timestamp":1759329508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422001933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":133,"alternative-id":["S0223523422001933"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114291","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114291"}}